Who founded Eugit Therapeutics?

Eugit Therapeutics was founded by Nizar Batada, Yoshi Fukazawa, George Church in 2022.

Who are Eugit Therapeutics's investors?

Eugit Therapeutics's investors include Y Combinator.

Where is Eugit Therapeutics headquartered?

Eugit Therapeutics is headquartered in San Francisco, US.

Eugit Therapeutics

YC S22

San Francisco, US · Founded 2022 · 2 employees · 1 known investors

Find your way into Eugit Therapeutics

Paths you didn't know you had: your email and LinkedIn already hold routes to the Eugit Therapeutics team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Tissue Targeting Therapies develops therapeutics targeting specific tissues using computational genomics and immunology. The company serves patients through drug development in the biotech/medtech space.

Also known as Eugit · Eugit Therapeutics Inc · EUGIT Tx · EUGIT Tx, EUGIT Therapeutics, Eugit, Eugit Therapeutics Inc

Biotech Healthtech Medical Devices Cell Therapy Synthetic Biology Therapeutics Oncology BiotechnologyUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (S22)

Eugit Therapeutics was founded in 2022 by Nizar Batada, Yoshi Fukazawa, and George Church.

Nizar Batada Co-FounderHe previously worked as a scientist at 23andMe and held a tenure-track position at the University of Edinburgh, with a PhD in Biophysics from Stanford and research background in cancer genomics and bioinformatics.

Yoshi Fukazawa VP of Research / Co-FounderYoshi Fukazawa is VP of Research and co-founder of Eugit Therapeutics, where he leads development of gamma delta T cell therapies. He brings extensive research background in immunology, virology, and cancer biology.

George Church Scientific Advisor / Co-FounderProfessor at Harvard and MIT with a PhD in molecular biology, Church developed foundational methods for direct genome sequencing and molecular multiplexing that contributed to next-generation sequencing technologies. He has founded multiple biotech companies spanning genomics, gene editing, and therapeutics, and directs PersonalGenomes.org, an open-access genomic data resource.

Investors · 1

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · open dataset · 5k.vc investor directory · Not right? Tell us

Related companies · 4

Modulari-TModulari-T develops proprietary cell therapy technologies, including the MARC receptor and MoVe platform, based on primary research into immune system architecture. The company serves the cell therapy and immunotherapy market.

WhiteLab GenomicsWhiteLab Genomics uses AI and computational methods to analyze biological data and accelerate genomic drug discovery and development. The company serves pharmaceutical and biotech organizations seeking to reduce timelines and de-risk the development of genomic medicines.

LEAH LabsLEAH Labs engineers gene-edited CAR-T cell therapies to treat cancer in pet dogs, with the goal of generating translational insights for human cancer therapy. The company uses proprietary gene editing and protein design to develop therapeutic treatments for companion animal oncology.

Indee LabsIndee Labs develops Hydropore™, a non-viral microfluidic technology for delivering molecules, nucleic acids, proteins, and gene-editing complexes into immune cells for engineered cell therapy research and manufacturing. The platform enables rapid production of high-quality T-cell immunotherapies and other cell therapies with preserved cell function.

Companies working in the same space as Eugit Therapeutics.

Legal entities · 1

corporate structure

Eugit Therapeutics, Inc.

In the news

EUGIT Therapeutics – Next generation T cell based cancer immunotherapyycombinator.com · Jul 2022

Frequently asked questions

What does Eugit Therapeutics do?: Tissue Targeting Therapies develops therapeutics targeting specific tissues using computational genomics and immunology. The company serves patients through drug development in the biotech/medtech space.
Who founded Eugit Therapeutics?: Eugit Therapeutics was founded by Nizar Batada, Yoshi Fukazawa, George Church in 2022.
Who are Eugit Therapeutics's investors?: Eugit Therapeutics's investors include Y Combinator.
Where is Eugit Therapeutics headquartered?: Eugit Therapeutics is headquartered in San Francisco, US.